Adem GÜNER, Canan ALBAY, Tamer AKKAN, Hakan BEKTAŞ, Elifsu POLATLI

Anticancer and antiangiogenesis activities of novel synthesized 2-substituted benzimidazoles molecules

In this study, novel 2-substituted benzimidazoles molecules having triazole, thiadiazole, and oxadiazole ringswere synthesized and were evaluated by anticancer, antioxidant/oxidant status, genotoxicity, and antiangiogenesis assays. Anticancer activity of the compounds was determined by MTT (0.5, 5, and 50 µg/mL) and lactate dehydrogenase (LDH) release assays against human prostate and breast cancer cells. Oxidative status of cells was elicited by total oxidative stress and total antioxidant capacity methods. Chick chorioallantoic membrane assay was used to evaluate the antiangiogenic activity. Genotoxicity was evaluated by the sister chromatid exchange (SCE) and micronucleus (MN) tests in lymphocyte cultured human blood. Our results showed that some of the compounds synthesized had significant antiproliferative activity against both cancer cell lines (between 4.54 ± 0.35 and 20.17 ± 3.15 µg/mL), with higher inhibition of the breast cancer, and caused inhibition of LDH release with a linear correlation to MTT results. Moreover, the 5 µg/mL dose of these molecules led to an increase in antioxidant levels. Compounds had antiangiogenic effectiveness in a dose-dependent manner. Additionally, all of the compounds did not affect SCE and MN levels compared to controls.In conclusion, these newly synthesized molecules can be a resource of new anticancer agents with their nongenotoxic, antiproliferative, and antiangiogenic properties.

PDF

___

1. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell 2006; 127 (4): 679-695. doi: 10.1016/j.cell.2006.11.001
2. American Cancer Society. Cancer Facts and Figures. New York, NY, USA: American Cancer Society, 2018.
3. World Health Organization. Global Health Observatory. Geneva: World Health Organization, 2018.
4. Bansal Y, Silakari O. The therapeutic journey of benzimidazoles: a review. Bioorganic & Medicinal Chemistry Letters 2012; 20 (21): 6208-6236. doi: 10.1016/j.bmc.2012.09.013
5. Kamil A, Akhtar S, Jahan S, Karim A, Rafiq K et al. Benzimidazole derivatives: active class of antioxidants. Journal of Scientific and Engineering Research 2013; 4 (8): 1674-1685.
6. Güven ÖÖ, Erdoğan T, Göker H, Yıldız S. Synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted benzyl ethers. Bioorganic & Medicinal Chemistry Letters 2007; 17 (8): 2233-2236. doi: 10.1016/j.bmcl.2007.01.061
7. Huang ST, Hsei IJ, Chen C. Synthesis and anticancer evaluation of bis (benzimidazoles), bis (benzoxazoles), and benzothiazoles. Bioorganic & Medicinal Chemistry Letters 2006; 14 (17): 6106-6119. doi: 10.1016/j.bmc.2006.05.007
8. Błaszczak-Świątkiewicz K, Olszewska P, Mikiciuk-Olasik E. Antiproliferative activity of new benzimidazole derivatives. Acta Biochimica Polonica 2013; 60 (3): 427-433.
9. Abonia R, Cortés E, Insuasty B, Quiroga J, Nogueras M et al. Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents. European Journal of Medicinal Chemistry 2011; 46 (9): 4062-4070. doi: 10.1016/j.ejmech.2011.06.006
10. Rashid M, Husain A, Mishra R. Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents. European Journal of Medicinal Chemistry 2012; 54: 855-866. doi: 10.1016/j.ejmech.2012.04.027
11. Yuan Z, Chen S, Chen C, Chen J, Chen C et al. Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy. European Journal of Medicinal Chemistry 2017; 138: 1135-1146. doi: 10.1016/j.ejmech.2017.07.050
12. Wang M, Han X, Zhou Z. New substituted benzimidazole derivatives: a patent review (2013–2014). Expert Opinion on Therapeutic Patents 2015; 25 (5): 595-612. doi: 10.1517/13543776.2015.1015987
13. Shrivastava N, Naim MJ, Alam MJ, Nawaz F, Ahmed S et al. Benzimidazole scaffold as anticancer agent: synthetic approaches and structure–activity relationship. Archiv der Pharmazie 2017; 350 (6): 1-80. doi: 10.1002/ardp.201700040
14. Husain A, Rashid M, Mishra R, Parveen S, Shin D et al. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents. Bioorganic & Medicinal Chemistry Letters 2012; 22 (17): 5438- 5444. doi: 10.1016/j.bmcl.2012.07.038
15. Abdel-Fattah HA, El-Etrawy AS, Gabr Noha RM. Synthesis and biological evaluation of some new 1, 3, 4- oxa,thiadiazole and 1, 2, 4-triazole derivatives attached to benzimidazole. International Journal of Pharmaceutical Chemistry 2014; 4 (3): 112-118. doi: 10.7439/ijpc.v4i3.91
16. Türkez H, Toğar B, Di Stefano A, Taşpınar N, Sozio P. Protective effects of cyclosativene on H2 O2 -induced injury in cultured rat primary cerebral cortex cells. Cytotechnology 2014; 67 (2): 299-309. doi: 10.1007/s10616-013-9685-9
17. Specian AFL, Serpeloni JM, Tuttis K, Ribeiro DL, Cilião HL et al. LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds. Cytotechnology 2016; 68 (6): 2729-2744. doi: 10.1007/s10616-016-9998-6
18. Güner A, Karabay Yavasoglu NÜ. Evaluation of antioxidant, antimicrobial and antimutagenic activity with irritation effects of Ceramium rubrum (red algae) extract. International Journal of Secondary Metabolite 2018; 5 (4): 279-287. doi: 10.21448/ijsm.432654
19. Sies H. Oxidative stress: oxidants and antioxidants. Experimental Physiology 1997; 82 (2): 291-295. doi: 10.1113/expphysiol.1997.sp004024
20. Güner A, Nalbantsoy A, Sukatar A, Karabay Yavaşoğlu NÜ. Apoptosis-inducing activities of Halopteris scoparia L. Sauvageau (brown algae) on cancer cells and its biosafety and antioxidant properties. Cytotechnology 2019; 71 (3): 687-704. doi: 10.1007/s10616-019-00314-5
21. Menteşe E, Ülker S, Kahveci B. Synthesis and study of α-glucosidase inhibitory, antimicrobial and antioxidant activities of some benzimidazole derivatives containing triazole, thiadiazole, oxadiazole, and morpholine rings. Chemistry of Heterocyclic Compounds 2015; 50 (12): 1671-1682. doi: 10.1007/s10593-015-1637-1
22. Enoch S, Leaper DJ. Basic science of wound healing. Surgery (Oxford) 2005; 23: 37-42. doi: 10.1383/surg.23.2.37.60352
23. Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vascular Health and Risk Management 2006; 2 (3): 213-219. doi: 10.2147/vhrm.2006.2.3.213
24. Rajabi M, Mousa SA. The role of angiogenesis in cancer treatment. Biomedicines 2017; 5 (2): 34. doi: 10.3390/biomedicines5020034
25. Ulus G, Koparal AT, Baysal K, Anacak GY, Karabay Yavasoğlu NÜ. The anti-angiogenic potential of (±) gossypol in comparison to suramin. Cytotechnology 2018; 70 (6): 1537-1550. doi: 10.1007/s10616-018-0247-z
26. Giovannini M, Aldrighetti D, Zucchinelli P, Belli C, Villa E. Antiangiogenic strategies in breast cancer management. Critical Reviews in Oncology/Hematology 2010; 76 (1): 13-35. doi: 10.1016/j.critrevonc.2009.12.004
27. Temirak A, Shaker YM, Ragab FAF, Ali MM, Ali HI et al. Part I. Synthesis, biological evaluation and docking studies of new 2-furyl benzimidazoles as antiangiogenic agents. European Journal of Medicinal Chemistry 2014; 87: 868-880. doi: 10.1016/j.ejmech.2014.01.063
28. El Nassan HB. Synthesis, antitumor activity and SAR study of novel [1,2,4] triazino [4,5-a] benzimidazole derivatives. European Journal of Medicinal Chemistry 2012; 53: 22-27. doi: 10.1016/j.ejmech.2012.03.028
29. Hori A, Imaeda Y, Kubo K, Kusaka M. Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo. Cancer Letters 2002; 183 (1): 53-60. doi: 10.1016/S0304- 3835(02)00110-6
30. Huang S, Lien J, Kuo S, Huang T. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Carcinogenesis 2012; 33 (5): 1022-1030. doi: 10.1093/carcin/bgs127
31. Yerragunta V, Patil P, Srujana S, Devi R, Gayathri R et al. Benzimidazole derivatives and its biological importance: a review. Pharma Tutor 2014; 2 (3): 109-113.
32. Can NÖ, Çevik UA, Sağlık BN, Özkay Y, Atlı Ö et al. Pharmacological and toxicological screening of novel benzimidazole-morpholine derivatives as dual-acting inhibitors. Molecules 2017; 22 (8): E1374. doi: 10.3390/molecules22081374
33. Van Hummelen P, Elhajouji A, Kirsch Volders M. Clastogenic and aneugenic effects of three benzimidazole derivatives in the in vitro micronucleus test using human lymphocytes. Mutagenesis 1995; 10 (1): 23-29. doi: 10.1093/mutage/10.1.23
34. Barale R, Scapoli C, Meli C, Casini D, Minunni M et al. Cytogenetic effects of benzimidazoles in mouse bone marrow. Mutation Research 1993; 300 (1): 15-28. doi: 10.1016/0165-1218(93)90135-Z
35. Padhy GK, Panda J, Raul SK, Behera AK. Synthesis of some new benzimidazole acid hydrazide derivatives as antibacterial agents. Indian Journal of Heterocyclic Chemistry 2018; 28 (4): 447-451.
36. Menteşe E, Bektaş H, Ülker S, Bekircan O, Kahveci B. Microwave-assisted synthesis of new benzimidazole derivatives with lipase inhibition activity. Journal of Enzyme Inhibition and Medicinal Chemistry 2014; 29 (1): 64-68. doi: 10.3109/14756366.2012.753880
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983; 65 (1-2): 55-63. doi: 10.1016/0022-1759(83)90303-4
38. Nalbantsoy A, İğci N, Göçmen B, Mebert K. Cytotoxic potential of Wagner’s Viper, Montivipera wagneri, venom. North-Western Journal of Zoology 2016; 12: 286-291.
39. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry 2004; 37 (4): 277-285. doi: 10.1016/j.clinbiochem.2003.11.015
40. Güner A, Türkez H, Aslan A. The in vitro effects of Dermotocarpon intestiniforme (a lichen) extracts against cadmium induced genetic and oxidative damage. Ekoloji 2012: 21: 38-46. doi: 10.5053/ekoloji.2012.845
41. Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005; 38 (12): 1103-1111. doi: 10.1016/j.clinbiochem.2005.08.008
42. Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hungerford DA. Chromosome preparations of leukocytes cultured from peripheral blood. Experimental Cell Research 1960; 20 (3): 613-616. doi: 10.1016/0014-4827(60)90138-5
43. Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature 1974; 251: 156-158. doi: 10.1038/251156a0
44. Fenech M, Morley AA. Measurement of micronuclei in lymphocytes. Mutation Research 1985; 147 (1-2): 29-36. doi: 10.1016/0165-1161(85)90015-9
45. Fenech M, Chang WP, Kirsch Volders M, Holland N, Bonassi S et al. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutation Research 2003; 534 (1-2): 65-75. doi: 10.1016/S1383-5718(02)00249-8